President Donald Trump is launching a project that aims to fast-track the development of a coronavirus vaccine. Called “Operation Warp Speed,” its goal is to manufacture millions of doses of the vaccine by the end of the year, according to CNN.
“I hope we’re going to have a vaccine and we’re going to fast-track a vaccine like you’ve never seen before if we come with a vaccine,” Donald Trump said during a meeting with New Jersey Gov. Phil Murphy at the White House, CNBC reported. “I think they probably will.”
The project’s goal might appear a bit optimistic but Trump is confident that it can be done. “I’m not overpromising,” he said. “Whatever the maximum is, whatever you can humanly do, we’re going to do.”
Trump also said that he will personally oversee the project. “I’m really in charge of it,” the POTUS said. “I think probably more than anything I’m in charge.”
There are multiple projects all over the world working on creating a coronavirus vaccine but it might take some time before their efforts bear fruit. According to the National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci, a vaccine for the virus might take between a year and 18 months to develop.
However, Donald Trump said that in Operation Warp Speed, both government researchers and pharmaceutical firms will join forces to shorten the development time of the vaccine, a cooperation that has been described as a Manhattan Project-like effort. The Manhattan Project was a World War II led by the U.S. with support from the U.K. Canada to develop the first atomic bomb and end the war.
The U.S. has the highest number of COVID-19 cases worldwide with more than 1.1 million Americans infected with the virus, according to data from Worldometers. The country also has the highest number of casualties with more than 67,000 deaths due to the disease.
One positive development in the country’s fight against the pandemic is that Gilead Sciences’ antiviral drug remdesivir showed positive outcomes in initial trials. COVID-19 patients who took the drug recovered 30 percent faster than those who took a placebo.


Marco Rubio Seeks Gulf Support for U.S.-Iran Peace Deal Amid Regional Concerns
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Republican Lawmaker Introduces AI Incident Reporting Bill to Strengthen U.S. AI Safety
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
US Reaffirms Taiwan Arms Sales Policy Despite Trump’s Comments on China
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies
Russia Signals Frustration Over Unfulfilled U.S. Commitments After Alaska Summit
Why the future of marijuana legalization remains hazy despite high public support
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Bessent Says U.S. Must Strengthen Supply Chains and Economic Security 



